Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (201-210 of 945) with videos related to

Pageof 95
Sort By:
Diagnostic Microbiology and Infectious Disease|July 25, 2000
Development of gemifloxacin in vitro susceptibility test methods for gonococci including quality control guidelines. The Quality Control Study GroupR N Jones, M E Erwin
Antimicrobial Agents and Chemotherapy|December 1, 1988
Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeaeG V Doern, R N Jones
Diagnostic Microbiology and Infectious Disease|March 27, 1999
Spectrum and antimicrobial activity of alexomycin (PNU-82, 127), a peptide compound projected for use in animal healthS A Marshall, R N Jones
Diagnostic Microbiology and Infectious Disease|January 1, 1995
Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonamD J Biedenbach, R N Jones
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1992
Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218D M Johnson, R N Jones
Postgraduate Medical Journal|January 1, 1983
The antimicrobial activity of cephalexin against old and new pathogensR N Jones, D A Preston
Journal of Chemotherapy (Florence, Italy)|February 1, 1994
Post-antibiotic effect of FK-037 and biapenem tested against five bacterial speciesA K Houston, R N Jones
The Journal of Antimicrobial Chemotherapy|January 1, 1989
Activity of cefepime (BMY-28142) and cefpirome (HR 810) against gram-negative bacilli resistant to cefotaxime or ceftazidimeR N Jones, P C Fuchs
Diagnostic Microbiology and Infectious Disease|May 1, 1989
Stability of SM-7338, a new carbapenem in mediums recommended for the susceptibility testing of anaerobic bacteria and gonococciR N Jones, R V Gardiner
Journal of Clinical Microbiology|September 1, 1993
Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study GroupM J Bale, R N Jones
Pageof 95

Showing results (201-210 of 945) with videos related to

Sort By:
Pageof 95
Diagnostic Microbiology and Infectious Disease|July 25, 2000
Development of gemifloxacin in vitro susceptibility test methods for gonococci including quality control guidelines. The Quality Control Study GroupR N Jones, M E Erwin
Antimicrobial Agents and Chemotherapy|December 1, 1988
Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeaeG V Doern, R N Jones
Diagnostic Microbiology and Infectious Disease|March 27, 1999
Spectrum and antimicrobial activity of alexomycin (PNU-82, 127), a peptide compound projected for use in animal healthS A Marshall, R N Jones
Diagnostic Microbiology and Infectious Disease|January 1, 1995
Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonamD J Biedenbach, R N Jones
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1992
Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218D M Johnson, R N Jones
Postgraduate Medical Journal|January 1, 1983
The antimicrobial activity of cephalexin against old and new pathogensR N Jones, D A Preston
Journal of Chemotherapy (Florence, Italy)|February 1, 1994
Post-antibiotic effect of FK-037 and biapenem tested against five bacterial speciesA K Houston, R N Jones
The Journal of Antimicrobial Chemotherapy|January 1, 1989
Activity of cefepime (BMY-28142) and cefpirome (HR 810) against gram-negative bacilli resistant to cefotaxime or ceftazidimeR N Jones, P C Fuchs
Diagnostic Microbiology and Infectious Disease|May 1, 1989
Stability of SM-7338, a new carbapenem in mediums recommended for the susceptibility testing of anaerobic bacteria and gonococciR N Jones, R V Gardiner
Journal of Clinical Microbiology|September 1, 1993
Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study GroupM J Bale, R N Jones
Pageof 95